3-iodobenzylguanidine has been researched along with MEA 2a in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Andrási, M; Barna, S; Berta, E; Bhattoa, HP; Bodor, M; Erdei, A; Gazdag, A; Győry, F; Hircsu, I; Kanyári, Z; Nagy, B; Nagy, VE | 1 |
| Díez, JJ; Fajardo, C; García-Sancho, P; Guerrero-Pérez, F; Iglesias, P; Marengo, AP; Pian, H; Santacruz, E; Villabona, C | 1 |
| Breza, J | 1 |
| Jiang, X; Tian, W; Wu, H; Yin, H; Zhang, Y; Zhou, X; Zhu, C | 1 |
| Drozd, T; Green, P; Hamdan, A; Hirsch, D; Molad, Y; Neumann, A | 1 |
| Kjaer, A; Petersen, CL | 1 |
| Davis, DB; Kaplan, EL; Kim, J; Refetoff, S; Reutrakul, S | 1 |
| Alac, M; Kovacic, K; Kusic, Z; Trnski, D | 1 |
| Inoue, J; Iwaoka, T; Naomi, S; Oishi, S; Sasaki, M; Sato, T; Tokunaga, H; Umeda, T; Yamauchi, J | 1 |
| Hara, Y; Hayashi, A; Horiike, S; Ishii, K; Kubo, A; Kusakabe, K; Masaki, H; Murata, H | 1 |
| De Graaf, JS; Dullaart, RP; Kok, T; Piers, DA; Zwierstra, RP | 1 |
| Chan, JC; Loke, TK; Tsang, MW; Tse, TW; Yung, BC | 1 |
| Bonjer, HJ; Boomsma, F; Bosman, FT; Bruining, HA; de Herder , WW; de Krijger , RR; Krenning, EP; Kwekkeboom, DJ; Lamberts, SW; Stijnen, T; van de Meiracker , AH; van der Harst, E | 1 |
1 trial(s) available for 3-iodobenzylguanidine and MEA 2a
| Article | Year |
|---|---|
[Evaluation of clinical utility of 123I-MIBG scintigraphy in localization of tumors of sympathetic and adrenomedullary origin--a report of multicenter phase III clinical trials].
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Carcinoma, Medullary; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2000 |
12 other study(ies) available for 3-iodobenzylguanidine and MEA 2a
| Article | Year |
|---|---|
[Multiple endocrine neoplasia type 2A in a family].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Female; Goiter, Nodular; Humans; Metanephrine; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Parathyroid Neoplasms; Pheochromocytoma; Ribosomal Proteins; Thyroid Neoplasms; Thyroid Nodule; Thyroidectomy | 2020 |
Pheochromocytoma: A three-decade clinical experience in a multicenter study.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Catecholamines; Conversion to Open Surgery; Doxazosin; Female; Humans; Hypertension; Male; Metanephrine; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Pancreatic Neoplasms; Phenoxybenzamine; Pheochromocytoma; Postoperative Complications; Retrospective Studies; Time Factors; Tumor Burden; Young Adult | 2021 |
Multiple endocrine neoplasia 2A (MEN 2A) syndrome.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Carcinoma, Neuroendocrine; Child; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Mutation; Pedigree; Pheochromocytoma; Polymerase Chain Reaction; Positron Emission Tomography Computed Tomography; Proto-Oncogene Mas; Proto-Oncogene Proteins c-ret; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2018 |
Diagnosis of multiple endocrine neoplasia type 2A in patients with positive thyroid imaging by iodine-131 metaiodobenzylguanidine scintigraphy.
Topics: 3-Iodobenzylguanidine; Adult; Female; Humans; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Radionuclide Imaging; Thyroid Gland | 2011 |
Pheochromocytoma: unusual presentation of a rare disease.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Antineoplastic Agents; Biopsy, Needle; Carcinoma, Medullary; Diagnosis, Differential; Disease-Free Survival; Follow-Up Studies; Humans; Low Back Pain; Lumbar Vertebrae; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Osteolysis; Pelvis; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Spinal Neoplasms; Thyroid Neoplasms; Thyroidectomy; Time Factors; Tomography, X-Ray Computed | 2002 |
Primary diagnosis of multiple pheochromocytomas in the brother of a MEN-2 patient by simultaneous MIBG scintigraphy and low-dose computed tomography.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Aged; Female; Genetic Predisposition to Disease; Genetic Testing; Humans; Liver Neoplasms; Male; Multiple Endocrine Neoplasia Type 2a; Pheochromocytoma; Radionuclide Imaging; Siblings; Tomography, X-Ray Computed | 2002 |
Multiple endocrine neoplasia 2A syndrome presenting as peripartum cardiomyopathy due to catecholamine excess.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Cardiomyopathies; Catecholamines; Female; Humans; Labor, Obstetric; Metanephrine; Multiple Endocrine Neoplasia Type 2a; Pedigree; Pheochromocytoma; Positron-Emission Tomography; Pregnancy; Proto-Oncogene Mas; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2004 |
I-131 MIBG and bone scintigraphy in a patient with MEN.
Topics: 3-Iodobenzylguanidine; Bone and Bones; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Neoplasm Invasiveness; Radionuclide Imaging | 1995 |
A case of Sipple's syndrome with malignant pheochromocytoma treated with 131I-metaiodobenzyl guanidine and a combined chemotherapy with cyclophosphamide, vincristine and dacarbazine.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Multiple Endocrine Neoplasia Type 2a; Pheochromocytoma; Vincristine | 1994 |
Limited role of meta-iodobenzylguanidine scintigraphy in imaging phaeochromocytoma in patients with multiple endocrine neoplasia type II.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Algorithms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2000 |
Sporadic bilateral adrenal medullary hyperplasia: apparent false positive MIBG scan and expected MRI findings.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenal Medulla; Adrenalectomy; Adult; Diagnosis, Differential; False Positive Reactions; Follow-Up Studies; Humans; Hyperplasia; Hypertension; Magnetic Resonance Imaging; Male; Multiple Endocrine Neoplasia Type 2a; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2000 |
[(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Disease-Free Survival; Humans; Indium Radioisotopes; Iodine Radioisotopes; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Neoplasm Metastasis; Octreotide; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Recurrence; Retrospective Studies; Survival Rate; Tissue Distribution | 2001 |